Evidence map›Paper›PMID 24038607›Full record

ArticleDevelopmental dynamics : an official publication of the American Association of Anatomists2013

SAS1B protein [ovastacin] shows temporal and spatial restriction to oocytes in several eutherian orders and initiates translation at the primary to secondary follicle transition.

Eusebio S Pires, Callie Hlavin, Ellen Macnamara, Khadijat Ishola-Gbenla, Christa Doerwaldt, Catherine Chamberlain, Kenneth Klotz, Austin K Herr, Aalok Khole, Olga Chertihin and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Developmental dynamics : an official publication of the American Association of Anatomists, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Eusebio S PiresDepartment of Cell Biology, Center for Research in Contraceptive and Reproductive Health, University of Virginia, Charlottesville, Virginia.
Callie Hlavin
Ellen Macnamara
Khadijat Ishola-Gbenla
Christa Doerwaldt
Catherine Chamberlain
Kenneth Klotz
Austin K Herr
Aalok Khole
Olga Chertihin
Eliza Curnow
Sandford H Feldman
Arabinda Mandal
Jagathpala Shetty
Charles Flickinger
John C Herr
University of Virginia · USUniversity of Washington · US

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
Institute of Translational Health SciencesUL1TR000423 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$49.4M
PROTEIN IMMUNOGENS OF THE HUMAN SPERM SURFACEU54HD029099 · NICHD · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HERR, JOHN C · 1991 to 2004
$6.2M
TRANSLATIONAL CONTRACEPTIVE RESEARCH FOR INDIAN POSTDOCSD43TW000654 · FIC · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HERR, JOHN C · 1995 to 2010
$2.2M
Structural Targeting Testis Specific Kinases (TSSK) 1 & 2 for Male ContraceptionU01HD060491 · NICHD · UNIVERSITY OF VIRGINIA · PI HERR, JOHN C · 2009 to 2013
$1.3M
IMMUNOLOGIC MECHANISMS IN HUMAN FEMALE INFERTILITYR01HD035523 · NICHD · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HERR, JOHN C · 1998 to 2002
$1.0M
IMMUNODOMINANT OVARIAN ANTIGENS INVOLVED IN PREMATURE OVARIAN FAILURER03HD055129 · NICHD · UNIVERSITY OF VIRGINIA · PI HERR, JOHN C · 2007 to 2008
$150k
FIC NIH HHS D43 TW000654NCATS NIH HHS UL1 TR000423NICHD NIH HHS D43TW/HD00654NICHD NIH HHS R01 HD035523NICHD NIH HHS R03 HD055129NICHD NIH HHS U01 HD060491NICHD NIH HHS U01HD60491-2S1NICHD NIH HHS U54 HD029099NIH HHS P51 OD010425NIH HHS P51OD010425
6 · The paper itself

Abstract

backgroundSperm Acrosomal SLLP1 Binding (SAS1B) protein (ovastacin) is an oolemmal binding partner for the intra-acrosomal sperm protein SLLP1.

resultsImmunohistochemical localization revealed that SAS1B translation is restricted among adult tissues to the ovary and oocytes, SAS1B appearing first in follicles at the primary-secondary transition. Quiescent oocytes within primordial follicles and primary follicles did not stain for SAS1B. Examination of neonatal rat ovaries revealed SAS1B expression first as faint signals in postnatal day 3 oocytes, with SAS1B protein staining intensifying with oocyte growth. Irrespective of animal age or estrus stage, SAS1B was seen only in oocytes of follicles that initiated a second granulosa cell layer. The precise temporal and spatial onset of SAS1B expression was conserved in adult ovaries in seven eutherian species, including nonhuman primates. Immunoelectron micrographs localized SAS1B within cortical granules in MII oocytes. A population of SAS1B localized on the oolemma predominantly in the microvillar region anti-podal to the nucleus in ovulated MII rat oocytes and on the oolemma in macaque GV oocytes.

conclusionsThe restricted expression of SAS1B protein in growing oocytes, absence in the ovarian reserve, and localization on the oolemma suggest this zinc metalloprotease deserves consideration as a candidate target for reversible female contraceptive strategies.

Indexed as

AnimalsBase SequenceBlotting, WesternCloning, MolecularCricetinaeDNA PrimersEvolution, MolecularFemaleGene Expression ProfilingGene Expression Regulation, DevelopmentalHumansImmunohistochemistryMammalsMetalloproteasesMiceMolecular Sequence DataASTL protein, humanDNA PrimersMetalloproteasesanimal contraceptionAstacin/ASTL/ovastacin/SAS1Bfertilizationoocyte biomarkersoocyte membrane proteinsoostatinreversible contraceptive

Identifiers

PMID24038607
PMCPMC4091973
OpenAlexW1499325509

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.